Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.

Manetti M, Romano E, Rosa I, Fioretto BS, Guiducci S, Bellando-Randone S, Pigatto E, Cozzi F, Ibba-Manneschi L, Matucci-Cerinic M.

Int J Mol Sci. 2019 Dec 7;20(24). pii: E6189. doi: 10.3390/ijms20246189.

2.

Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS).

Mavrogeni S, Gargani L, Pepe A, Monti L, Markousis-Mavrogenis G, Santis M, Marchi D, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Bratis K, Bellando-Randone S, Guiducci S, Bruni C, Moggi-Pignone A, Dimitroulas T, Kolovou G, Bournia VK, Sfikakis PP, Matucci-Cerinic M.

Rheumatology (Oxford). 2019 Nov 25. pii: kez494. doi: 10.1093/rheumatology/kez494. [Epub ahead of print]

PMID:
31764972
3.

One year in review 2019: systemic sclerosis.

Barsotti S, Orlandi M, Codullo V, Di Battista M, Lepri G, Della Rossa A, Guiducci S.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):3-14. Epub 2019 Oct 3. Review.

4.

The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs.

Bruni C, Rosato E, Maestripieri V, Gigante A, Tesei G, Bellando-Randone S, Guiducci S, Chiostri M, El Aoufy K, Blagojevic J, Moggi-Pignone A, De Paulis A, Furst DE, Boddi M, Matucci-Cerinic M.

Eur J Intern Med. 2019 Dec;70:43-49. doi: 10.1016/j.ejim.2019.09.001. Epub 2019 Sep 17.

PMID:
31540806
5.

Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis.

Blagojevic J, AlOdhaibi KA, Aly AM, Bellando-Randone S, Lepri G, Bruni C, Moggi-Pignone A, Guiducci S, Mecacci F, Matucci-Cerinic M, Furst DE.

J Rheumatol. 2019 Sep 1. pii: jrheum.181460. doi: 10.3899/jrheum.181460. [Epub ahead of print]

PMID:
31474594
6.

Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic Implications.

Manetti M, Romano E, Rosa I, Fioretto BS, Praino E, Guiducci S, Iannone F, Ibba-Manneschi L, Matucci-Cerinic M.

J Clin Med. 2019 Aug 19;8(8). pii: E1256. doi: 10.3390/jcm8081256.

7.

Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study.

Terenzi R, Karalilova R, Lepri G, Bruni C, Bellando-Randone S, Manetti M, Romano E, Melchiorre D, Blagojevic J, Wang Y, Solanki K, Moggi-Pignone A, Batalov Z, Guiducci S, Batalov A, Matucci-Cerinic M.

Rheumatology (Oxford). 2019 Aug 13. pii: kez322. doi: 10.1093/rheumatology/kez322. [Epub ahead of print]

PMID:
31410485
8.

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study.

Valentini G, Huscher D, Riccardi A, Fasano S, Irace R, Messiniti V, Matucci-Cerinic M, Guiducci S, Distler O, Maurer B, Avouac J, Tarner IH, Frerix M, Riemekasten G, Siegert E, Czirják L, Lóránd V, Denton CP, Nihtyanova S, Walker UA, Jaeger VK, Del Galdo F, Abignano G, Ananieva LP, Gherghe AM, Mihai C, Henes JC, Schmeiser T, Vacca A, Moiseev S, Foeldvari I, Gabrielli A, Krummel-Lorenz B, Rednic S, Allanore Y, Müeller-Ladner U.

Ann Rheum Dis. 2019 Nov;78(11):1576-1582. doi: 10.1136/annrheumdis-2019-215486. Epub 2019 Aug 7.

PMID:
31391176
9.

Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do?

Bargagli E, Mazzei MA, Orlandi M, Gentili F, Bellisai F, Frediani B, Bergantini L, Carobene L, Randone SB, Guiducci S, Cameli P, Bruni C, Cerinic MM.

Medicine (Baltimore). 2019 Jun;98(26):e16086. doi: 10.1097/MD.0000000000016086.

10.

Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Blagojevic J, Abignano G, Avouac J, Cometi L, Frerix M, Bellando-Randone S, Guiducci S, Bruni C, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Czirják L, Denton CP, Distler O, Allanore Y, Müller-Ladner U, Moggi-Pignone A, Matucci-Cerinic M, Del Galdo F; EUSTAR co-workers.

Clin Rheumatol. 2020 Jan;39(1):27-36. doi: 10.1007/s10067-019-04564-8. Epub 2019 May 20.

PMID:
31111363
11.

A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems.

Romano E, Rosa I, Fioretto BS, Guiducci S, Manetti M, Matucci-Cerinic M.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):133-140. Epub 2019 Apr 11. Review.

12.

Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study.

Negrini S, Magnani O, Matucci-Cerinic M, Carignola R, Data V, Montabone E, Santaniello A, Adorni G, Murdaca G, Puppo F, Indiveri F, Della Rossa A, D'Ascanio A, Barsotti S, Giuggioli D, Ferri C, Lumetti F, Bosello SL, Canestrari G, Bellando Randone S, Bruni C, Guiducci S, Battaglia E, De Andres MI, Russo AA, Beretta L.

Clin Exp Med. 2019 Aug;19(3):357-366. doi: 10.1007/s10238-019-00553-y. Epub 2019 Apr 15.

PMID:
30989453
13.

Culture and Real-time Polymerase Chain reaction sensitivity in the diagnosis of invasive meningococcal disease: Does culture miss less severe cases?

Guiducci S, Moriondo M, Nieddu F, Ricci S, De Vitis E, Casini A, Poggi GM, Indolfi G, Resti M, Azzari C.

PLoS One. 2019 Mar 13;14(3):e0212922. doi: 10.1371/journal.pone.0212922. eCollection 2019.

14.

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey.

Blagojevic J, Bellando-Randone S, Abignano G, Avouac J, Cometi L, Czirják L, Denton CP, Distler O, Frerix M, Guiducci S, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Allanore Y, Müller-Ladner U, Del Galdo F, Matucci-Cerinic M; EUSTAR co-workers.

Arthritis Res Ther. 2019 Jan 24;21(1):35. doi: 10.1186/s13075-019-1822-1.

15.

Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging.

Gargani L, Todiere G, Guiducci S, Bruni C, Pingitore A, De Marchi D, Bellando Randone S, Aquaro GD, Bazzichi L, Mosca M, Lombardi M, Pepe A, Matucci-Cerinic M, Picano E.

JACC Cardiovasc Imaging. 2019 May;12(5):927-928. doi: 10.1016/j.jcmg.2018.09.025. Epub 2018 Dec 12. No abstract available.

PMID:
30553664
16.

Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis.

Bruni C, Ngcozana T, Braschi F, Pucci T, Piemonte G, Benelli L, Poli M, Suliman YA, Guiducci S, Bellando-Randone S, Balduzzi S, Grotts J, Denton CP, Rasero L, Montecucco C, Furst DE, Matucci-Cerinic M.

J Rheumatol. 2019 Jun;46(6):603-608. doi: 10.3899/jrheum.171486. Epub 2018 Nov 15.

PMID:
30442833
17.

18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis.

Bellando-Randone S, Tartarelli L, Cavigli E, Tofani L, Bruni C, Lepri G, Blagojevic J, Moggi-Pignone A, Mihai C, Avouac J, Passeri A, De Cristofaro MT, Distler O, Allanore Y, Guiducci S, Matucci-Cerinic M.

Ann Rheum Dis. 2019 Apr;78(4):577-578. doi: 10.1136/annrheumdis-2018-213376. Epub 2018 Oct 18. No abstract available.

PMID:
30337426
18.

Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis.

Manetti M, Pratesi S, Romano E, Rosa I, Bruni C, Bellando-Randone S, Guiducci S, Maggi E, Ibba-Manneschi L, Matucci-Cerinic M.

Ann Rheum Dis. 2019 Apr;78(4):575-577. doi: 10.1136/annrheumdis-2018-214240. Epub 2018 Oct 12. No abstract available.

PMID:
30315003
19.

One year in review 2018: systemic sclerosis.

Orlandi M, Barsotti S, Lepri G, Codullo V, Di Battista M, Guiducci S, Della Rossa A.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):3-23. Epub 2018 Sep 28. Review.

20.

The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction.

Fiori G, Marzi T, Bartoli F, Bruni C, Ciceroni C, Palomba M, Zolferino M, Corsi E, Galimberti M, Moggi Pignone A, Viggiano MP, Guiducci S, Calamai M, Matucci-Cerinic M.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):135-141. Epub 2018 Sep 20.

PMID:
30277859
21.

Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

Bruni C, Frech T, Manetti M, Rossi FW, Furst DE, De Paulis A, Rivellese F, Guiducci S, Matucci-Cerinic M, Bellando-Randone S.

Front Immunol. 2018 Sep 7;9:2045. doi: 10.3389/fimmu.2018.02045. eCollection 2018. Review.

22.

Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis.

Romano E, Manetti M, Rosa I, Fioretto BS, Ibba-Manneschi L, Matucci-Cerinic M, Guiducci S.

Ann Rheum Dis. 2018 Nov;77(11):1665-1674. doi: 10.1136/annrheumdis-2018-213239. Epub 2018 Jul 18.

PMID:
30021803
23.

Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial design.

Hughes M, Tracey A, Bhushan M, Chakravarty K, Denton CP, Dubey S, Guiducci S, Muir L, Ong V, Parker L, Pauling JD, Prabu A, Rogers C, Roberts C, Herrick AL.

J Scleroderma Relat Disord. 2018 Jun 1;3(2):170-174. doi: 10.1177/2397198318764796. Epub 2018 Mar 27.

24.

The safety of iloprost in systemic sclerosis in a real-life experience.

Bellando-Randone S, Bruni C, Lepri G, Fiori G, Bartoli F, Conforti ML, Moggi-Pignone A, Guiducci S, Giuggioli D, Colaci M, Spinella A, Ferri C, Matucci-Cerinic M.

Clin Rheumatol. 2018 May;37(5):1249-1255. doi: 10.1007/s10067-018-4043-0. Epub 2018 Feb 22.

PMID:
29470737
25.

Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium.

Terenzi R, Manetti M, Rosa I, Romano E, Galluccio F, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M.

Sci Rep. 2017 Oct 16;7(1):13293. doi: 10.1038/s41598-017-13746-w.

26.

One year in review 2017: systemic sclerosis.

Barsotti S, Bruni C, Orlandi M, Della Rossa A, Marasco E, Codullo V, Guiducci S.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):3-20. Epub 2017 Sep 29. Review.

27.

Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study.

Colaci M, Lumetti F, Giuggioli D, Guiducci S, Bellando-Randone S, Fiori G, Matucci-Cerinic M, Ferri C.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):179-183. Epub 2017 Sep 18.

PMID:
28980901
28.

Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.

Manetti M, Pratesi S, Romano E, Bellando-Randone S, Rosa I, Guiducci S, Fioretto BS, Ibba-Manneschi L, Maggi E, Matucci-Cerinic M.

PLoS One. 2017 Aug 10;12(8):e0183102. doi: 10.1371/journal.pone.0183102. eCollection 2017.

29.

The "myth" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?

Matucci-Cerinic M, Manetti M, Bruni C, Chora I, Bellando-Randone S, Lepri G, De Paulis A, Guiducci S.

Arthritis Res Ther. 2017 Jul 6;19(1):162. doi: 10.1186/s13075-017-1370-5.

30.

Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis.

Chora I, Romano E, Manetti M, Mazzotta C, Costa R, Machado V, Cortez A, Bruni C, Lepri G, Guiducci S, De Paulis A, Soares R, Matucci-Cerinic M.

J Rheumatol. 2017 Aug;44(8):1190-1197. doi: 10.3899/jrheum.160791. Epub 2017 May 15.

PMID:
28507177
31.

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

Jaeger VK, Distler O, Maurer B, Czirják L, Lóránd V, Valentini G, Vettori S, Del Galdo F, Abignano G, Denton C, Nihtyanova S, Allanore Y, Avouac J, Riemekasten G, Siegert E, Huscher D, Matucci-Cerinic M, Guiducci S, Frerix M, Tarner IH, Garay Toth B, Fankhauser B, Umbricht J, Zakharova A, Mihai C, Cozzi F, Yavuz S, Hunzelmann N, Rednic S, Vacca A, Schmeiser T, Riccieri V, García de la Peña Lefebvre P, Gabrielli A, Krummel-Lorenz B, Martinovic D, Ancuta C, Smith V, Müller-Ladner U, Walker UA.

Rheumatology (Oxford). 2018 Mar 1;57(3):441-450. doi: 10.1093/rheumatology/kex182.

PMID:
28499034
32.

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

Beyer C, Huscher D, Ramming A, Bergmann C, Avouac J, Guiducci S, Meier F, Vettori S, Siegert E, Jaeger VK, Maurer B, Riemekasten G, Walker U, Müller-Ladner U, Valentini G, Matucci-Cerinic M, Allanore Y, Distler O, Schett G, Distler JHW.

Ann Rheum Dis. 2018 Apr;77(4):626-628. doi: 10.1136/annrheumdis-2016-210834. Epub 2017 May 11. No abstract available.

PMID:
28495672
33.

Avascular bone necrosis: An underestimated complication of systemic sclerosis.

Bruni C, Guiducci S, Bellando-Randone S, Matucci-Cerinic M.

Semin Arthritis Rheum. 2017 Aug;47(1):e3-e5. doi: 10.1016/j.semarthrit.2017.03.015. Epub 2017 Mar 21. No abstract available.

PMID:
28438381
34.

Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Benucci M, Gobbi FL, Guiducci S, Foti R, Mosca M, Goletti D.

Semin Arthritis Rheum. 2017 Oct;47(2):183-192. doi: 10.1016/j.semarthrit.2017.03.008. Epub 2017 Mar 22. Review.

PMID:
28413099
35.

Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.

Mazzotta C, Manetti M, Rosa I, Romano E, Blagojevic J, Bellando-Randone S, Bruni C, Lepri G, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M.

Arthritis Res Ther. 2017 Feb 10;19(1):27. doi: 10.1186/s13075-017-1233-0.

36.

One year in review 2016: spondyloarthritis.

Parma A, Cometi L, Leone MC, Lepri G, Talarico R, Guiducci S.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):3-17. Epub 2017 Jan 26. Review.

37.

Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.

Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, Ibba-Manneschi L, Matucci-Cerinic M.

Ann Rheum Dis. 2017 May;76(5):924-934. doi: 10.1136/annrheumdis-2016-210229. Epub 2017 Jan 6.

PMID:
28062404
38.

Update of EULAR recommendations for the treatment of systemic sclerosis.

Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors.

Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.

39.

Hydroxychloroquine and joint involvement in systemic sclerosis: Preliminary beneficial results from a retrospective case-control series of an EUSTAR center.

Bruni C, Praino E, Guiducci S, Bellando-Randone S, Furst DE, Matucci-Cerinic M.

Joint Bone Spine. 2017 Dec;84(6):747-748. doi: 10.1016/j.jbspin.2016.10.002. Epub 2016 Dec 5. No abstract available.

PMID:
27932280
40.

Effects of rituximab in connective tissue disorders related interstitial lung disease.

Lepri G, Avouac J, Airò P, Anguita Santos F, Bellando-Randone S, Blagojevic J, Garcia Hernàndez F, Gonzalez Nieto JA, Guiducci S, Jordan S, Limaye V, Maurer B, Selva-O'Callaghan A, Riccieri V, Distler O, Matucci-Cerinic M, Allanore Y.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):181-185. Epub 2016 Oct 14.

41.

Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient.

Bruni C, Bellando-Randone S, Gargani L, Picano E, Pingitore A, Matucci-Cerinic M, Guiducci S.

Reumatismo. 2016 Sep 9;68(2):109-11. doi: 10.4081/reumatismo.2016.889.

42.

Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments.

Besson M, Guiducci S, Granon S, Guilloux JP, Guiard B, Repérant C, Faure P, Pons S, Cannazza G, Zoli M, Gardier AM, Maskos U.

Psychopharmacology (Berl). 2016 Sep;233(18):3297-314. doi: 10.1007/s00213-016-4362-2. Epub 2016 Jul 6.

43.

Calcinosis in systemic sclerosis: subsets, distribution and complications.

Bartoli F, Fiori G, Braschi F, Amanzi L, Bruni C, Blagojevic J, Bellando-Randone S, Cometi L, de Souza Mueller C, Guiducci S, Rasero L, Epifani F, Furst DE, Matucci-Cerinic M.

Rheumatology (Oxford). 2016 Sep;55(9):1610-4. doi: 10.1093/rheumatology/kew193. Epub 2016 May 30.

PMID:
27241706
44.

A New Way of Thinking about Systemic Sclerosis: The Opportunity for a Very Early Diagnosis.

Guiducci S, Bellando-Randone S, Matucci-Cerinic M.

Isr Med Assoc J. 2016 Mar-Apr;18(3-4):141-3.

45.

The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?

Manetti M, Guiducci S, Matucci-Cerinic M.

Arthritis Res Ther. 2016 Feb 5;18:36. doi: 10.1186/s13075-016-0937-x.

46.

Assessment, Definition, and Classification of Lower Limb Ulcers in Systemic Sclerosis: A Challenge for the Rheumatologist.

Blagojevic J, Piemonte G, Benelli L, Braschi F, Fiori G, Bartoli F, Guiducci S, Bellando Randone S, Galluccio F, Cometi L, Castellani S, Boddi M, Moggi Pignone A, Rasero L, Epifani F, Matucci-Cerinic M.

J Rheumatol. 2016 Mar;43(3):592-8. doi: 10.3899/jrheum.150035. Epub 2016 Feb 1.

PMID:
26834223
47.

One year in review 2015: spondyloarthritis.

Giovannini L, Orlandi M, Lodato C, Cioffi E, Tenti S, Bardelli M, Talarico R, Guiducci S.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):769-78. Epub 2015 Dec 15.

PMID:
26690889
48.

Combination therapy with Bosentan and Sildenafil improves Raynaud's phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis.

Bellando-Randone S, Lepri G, Bruni C, Blagojevic J, Radicati A, Cometi L, De Paulis A, Matucci-Cerinic M, Guiducci S.

Clin Rheumatol. 2016 Jan;35(1):127-32. doi: 10.1007/s10067-015-3119-3. Epub 2015 Dec 3.

PMID:
26631100
49.

Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.

Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Giulio Favalli E, Becciolini A, Biggioggero M, Benucci M, Li Gobbi F, Grossi V, Infantino M, Meacci F, Manfredi M, Guiducci S, Bellando-Randone S, Matucci-Cerinic M, Foti R, Di Gangi M, Mosca M, Tani C, Palmieri F, Goletti D; Italian board for the TAilored BIOlogic therapy (ITABIO).

Semin Arthritis Rheum. 2016 Apr;45(5):519-32. doi: 10.1016/j.semarthrit.2015.10.001. Epub 2015 Oct 22. Review.

PMID:
26607440
50.

Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.

Romano E, Chora I, Manetti M, Mazzotta C, Rosa I, Bellando-Randone S, Blagojevic J, Soares R, Avouac J, Allanore Y, Ibba-Manneschi L, Matucci-Cerinic M, Guiducci S.

Ann Rheum Dis. 2016 Aug;75(8):1541-9. doi: 10.1136/annrheumdis-2015-207483. Epub 2015 Sep 10.

PMID:
26359450

Supplemental Content

Loading ...
Support Center